Overhead phototherapy units with CFL technology incorporate features such as adjustable intensity controls and built-in safeguards to monitor and control the temperature, ensuring a safe and comfortable environment for the newborn. Neonatal jaundice occurs when there is an accumulation of bilirubin, a yellow pigment produced during the breakdown of red blood cells. The liver in newborns is not always efficient in processing bilirubin, leading to its buildup and subsequent jaundice. Phototherapy is a non-invasive treatment that helps break down bilirubin into forms that the body can easily eliminate. The integration of CFL technology into overhead phototherapy units represents a significant step forward in neonatal care. This innovation enhances the efficiency, safety, and sustainability of phototherapy, ultimately contributing to better outcomes for newborns affected by jaundice. As technology continues to advance, the healthcare industry can look forward to even more sophisticated solutions that further refine and improve neonatal care practices.